Ray Therapeutics
Initial Transaction Details
Transaction Date
May 2023
Purpose of Financing
Venture
Stage of Company
Mid Stage
Structure of Financing
Equity
Ray Therapeutics is developing novel optogenetics gene therapies for patients with blinding diseases. The company’s mission is to use optogenetics to restore vision, independent of genetic mutation for patients with inherited retinal diseases. Ray Therapeutics is based in San Francisco, CA.
Website